ARTICLE | Clinical News
TK54 regulatory update
August 1, 2011 7:00 AM UTC
The European Commission granted Orphan Drug designation for LTKfarma's TK54 to treat acute lymphoblastic leukemia (ALL). The allogeneic T cells encoding an exogenous thymidine kinase gene has Orphan D...